Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes

Arthritis and Rheumatism

Volumn 65, Issue 8, 2013, Pages 2113-2122

  Stradner, Martin H ^a   Gruber, Gerald ^b   Angerer, Hannes ^b   Huber, Verena ^b   Setznagl, Daniela ^b   Kremser, Marie Luise ^b   Moazedi Fürst, Florentine C ^b   Windhager, Reinhard ^b,c   Graninger, Winfried B ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AGGRECANASE 1; COLLAGENASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RECEPTOR SUBTYPE; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL CULTURE; ENZYME PHOSPHORYLATION; EX VIVO STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; TOTAL KNEE REPLACEMENT; WESTERN BLOTTING;

ADAM PROTEINS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; DRUG ANTAGONISM; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; INTERLEUKIN-1BETA; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 13; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROCOLLAGEN N-ENDOPEPTIDASE; RECEPTORS, LYSOSPHINGOLIPID; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84881336705     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37989     Document Type: Article

References (38)

1. Loeser RF, Goldring SR, Scanzello CR, Goldring MB,. Osteoarthritis: a disease of the joint as an organ [review]. Arthritis Rheum 2012; 64: 1697-707.
2. Liu-Bryan R, Terkeltaub R,. The growing array of innate inflammatory ignition switches in osteoarthritis [editorial]. Arthritis Rheum 2012; 64: 2055-8.
3. Konttinen YT, Sillat T, Barreto G, Ainola M, Nordstrom DC,. Osteoarthritis as an autoinflammatory disease caused by chondrocyte-mediated inflammatory responses. Arthritis Rheum 2012; 64: 613-6.
4. Westacott CI, Sharif M,. Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 1996; 25: 254-72.
5. Van Beuningen HM, Arntz O, van den Berg WB,. In vivo effects of interleukin-1 on articular cartilage: prolongation of proteoglycan metabolic disturbances in old mice. Arthritis Rheum 1991; 34: 606-15.
6. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T,. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002; 46: 2648-57.
7. 2 production in human chondrocytes. Osteoarthritis Cartilage 2008; 16: 1267-74.
8. Van de Loo FA, Arntz OJ, Van den Berg WB,. Effect of interleukin-1 and leukemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis. Cytokine 1997; 9: 453-62.
9. Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997; 324: 305-10.
10. Blanco FJ, Ochs RL, Schwarz H, Lotz M,. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146: 75-85.
11. Van den Berg WB, van de Loo F, Joosten LA, Arntz OJ,. Animal models of arthritis in NOS2-deficient mice. Osteoarthritis Cartilage 1999; 7: 413-5.
12. Clements KM, Price JS, Chambers MG, Visco DM, Poole AR, Mason RM,. Gene deletion of either interleukin-1β, interleukin-1β-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum 2003; 48: 3452-63.
13. Spitsin SV, Koprowski H, Michaels FH,. Characterization and functional analysis of the human inducible nitric oxide synthase gene promoter. Mol Med 1996; 2: 226-35.
14. Badger AM, Roshak AK, Cook MN, Newman-Tarr TM, Swift BA, Carlson K, et al. Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage 2000; 8: 434-43.
15. Hung LF, Lai JH, Lin LC, Wang SJ, Hou TY, Chang DM, et al. Retinoid acid inhibits IL-1-induced iNOS, COX-2 and chemokine production in human chondrocytes. Immunol Invest 2008; 37: 675-93.
16. Stradner MH, Hermann J, Angerer H, Setznagl D, Sunk IG, Windhager R, et al. Spingosine-1-phosphate stimulates proliferation and counteracts interleukin-1 induced nitric oxide formation in articular chondrocytes. Osteoarthritis Cartilage 2008; 16: 305-11.
17. Olivera A, Spiegel S,. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 1993; 365: 557-60.
18. i-coupled cell surface receptor: potential involvement in angiogenesis. J Biol Chem 1999; 274: 35343-50.
19. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 2000; 106: 951-61.
20. Kluk MJ, Hla T,. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta 2002; 1582: 72-80.
21. Kim MK, Lee HY, Kwak JY, Park JI, Yun J, Bae YS,. Sphingosine-1-phosphate stimulates rat primary chondrocyte proliferation. Biochem Biophys Res Commun 2006; 345: 67-73.
22. 2 from human articular chondrocytes. BMC Musculoskelet Disord 2007; 8: 29.
23. Kitano M, Hla T, Sekiguchi M, Kawahito Y, Yoshimura R, Miyazawa K, et al. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression [published erratum appears in Arthritis Rheum 2006;54:1704]. Arthritis Rheum 2006; 54: 742-53.
24. Pi X, Tan SY, Hayes M, Xiao L, Shayman JA, Ling S, et al. Sphingosine kinase 1-mediated inhibition of Fas death signaling in rheumatoid arthritis B lymphoblastoid cells. Arthritis Rheum 2006; 54: 754-64.
25. Moon MH, Jeong JK, Lee YJ, Seol JW, Park SY,. Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes. Int J Mol Med 2012; 30: 1451-8.
26. Masuko K, Murata M, Beppu M, Nakamura H, Kato T, Yudoh K,. Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis. Int J Rheum Dis 2012; 15: 366-73.
27. Fuerst FC, Gruber G, Stradner MH, Jones JC, Kremser ML, Angerer H, et al. Regulation of MMP3 by laminin α4 in human osteoarthritic cartilage. Scand J Rheumatol 2011; 40: 494-6.
28. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006; 14: 13-29.
29. Stradner MH, Angerer H, Ortner T, Fuerst FC, Setznagl D, Kremser ML, et al. The immunosuppressant FTY720 (fingolimod) enhances glycosaminoglycan depletion in articular cartilage. BMC Musculoskelet Disord 2011; 12: 279.
30. Skoura A, Hla T,. Regulation of vascular physiology and pathology by the S1P2 receptor subtype. Cardiovasc Res 2009; 82: 221-8.
31. Sanchez T, Thangada S, Wu MT, Kontos CD, Wu D, Wu H, et al. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc Natl Acad Sci U S A 2005; 102: 4312-7.
32. Wang F, Okamoto Y, Inoki I, Yoshioka K, Du W, Qi X, et al. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest 2010; 120: 3979-95.
33. Gonda K, Okamoto H, Takuwa N, Yatomi Y, Okazaki H, Sakurai T, et al. The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. Biochem J 1999; 337: 67-75.
34. Yamaguchi H, Kitayama J, Takuwa N, Arikawa K, Inoki I, Takehara K, et al. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem J 2003; 374: 715-22.
35. 2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford) 2008; 47: 425-31.
36. Cheng AW, Stabler TV, Bolognesi M, Kraus VB,. Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthritis Cartilage 2011; 19: 118-25.
37. Mendes AF, Caramona MM, Carvalho AP, Lopes MC,. Role of mitogen-activated protein kinases and tyrosine kinases on IL-1-induced NF-κB activation and iNOS expression in bovine articular chondrocytes. Nitric Oxide 2002; 6: 35-44.
38. Bolli MH, Lescop C, Nayler O,. Synthetic sphingosine 1-phosphate receptor modulators-opportunities and potential pitfalls. Curr Top Med Chem 2011; 11: 726-57.